BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28581385)

  • 1. Prostate Cancer With Isolated Bony Metastasis: Sternal Struggle.
    Corkum MT
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):492-493. PubMed ID: 28581385
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapsing Prostate Cancer: Castrate or Cure?
    Tharmalingam H; Choudhury A
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1095-1096. PubMed ID: 29722651
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of prostate cancer associated with osteolytic bone metastases].
    Migita T; Maeda K; Ogata N
    Hinyokika Kiyo; 1999 May; 45(5):371-4. PubMed ID: 10410324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
    Jereczek-Fossa BA; Beltramo G; Fariselli L; Fodor C; Santoro L; Vavassori A; Zerini D; Gherardi F; Ascione C; Bossi-Zanetti I; Mauro R; Bregantin A; Bianchi LC; De Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):889-97. PubMed ID: 21277113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
    García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
    Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chest-Wall Metastasis of Prostate Cancer.
    Matei V; Bhushan S
    J Gen Intern Med; 2015 Dec; 30(12):1888. PubMed ID: 25759188
    [No Abstract]   [Full Text] [Related]  

  • 7. Bulging Tumor in the Distal Rectum.
    Huang CS; Huang LK; Yang JD
    Gastroenterology; 2020 Jun; 158(8):2061-2062. PubMed ID: 32142780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regarding a case of prostate cancer in a young male].
    Guerra del Barrio E; Escribano Sevillano D; Sánchez Gómez FJ; Ojer Tsakiridu D
    Rev Clin Esp; 2004 Apr; 204(4):236-7. PubMed ID: 15104939
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic therapeutic strategies for prostate cancer.
    Nelson WG
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):619-21. PubMed ID: 16167046
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carcinoma of the prostate: correlation between local staging and systemic progression].
    Rosi P; Marzi M; Mearini E; Bracarda S; Valli PP; Petroni PA; Porena M
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):91-5. PubMed ID: 9162385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer involving bilateral seminal vesicles along with bone and testicular metastases: a case report.
    Gao Q; Chen J; Dai Y
    J Med Case Rep; 2018 Mar; 12(1):72. PubMed ID: 29519246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
    Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M
    Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation therapy in patients with advanced prostate cancer.
    Dreicer R
    J Support Oncol; 2010; 8(5):209-11. PubMed ID: 21086878
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostatic carcinoma.
    Lawton CA; Grignon D; Newhouse JH; Schellhammer PF; Kuban DA
    Radiographics; 1999; 19(1):185-203. PubMed ID: 9925399
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy.
    Shimizu N; Masuda H; Yamanaka H; Oriuchi N; Inoue T; Endo K
    J Urol; 1999 Feb; 161(2):608-9. PubMed ID: 9915462
    [No Abstract]   [Full Text] [Related]  

  • 17. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal 18F-NaF PET Prostate Activity in the Setting of Prostate Adenocarcinoma.
    Chiang J; Gershenson JP; Lewis MS; Vahidi K; Berenji GR
    Clin Nucl Med; 2020 Jul; 45(7):e334-e335. PubMed ID: 32404713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmetastatic Castration-resistant Prostate Cancer: A Modern Perspective.
    Cancian M; Renzulli JF
    Urology; 2018 Jun; 116():13-16. PubMed ID: 29357298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitary sternal metastasis of nasopharyngeal carcinoma: a case report.
    Akbas T; Ugurluer G; Arpaci T
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1947-50. PubMed ID: 23242721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.